Yaxi Chen
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Peroxisome Proliferator-Activated Receptors 6
- Epidemiology 15
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 3
- Autophagy in Disease and Therapy 3
- Co-authors
- Xiong Z. Ruan (33 shared papers)Zac Varghese (13 shared papers)John F. Moorhead (12 shared papers)Lei Zhao (16 shared papers)Ping Yang (8 shared papers)Stephen H. Powis (2 shared papers)Han Zeng (4 shared papers)Wei Li (4 shared papers)
- Journals
- PLoS ONE (3 papers)Biochemical and Biophysical Research Communications (3 papers)Cell Death and Disease (2 papers)Scientific Reports (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yaxi Chen
49 papers receiving 2.0k citations
Yaxi Chen's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 509
- Hepatology 159
- Nephrology 104
- Epidemiology 477
- Biochemistry 106
Countries citing papers authored by Yaxi Chen
This map shows the geographic impact of Yaxi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaxi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaxi Chen more than expected).
Fields of papers citing papers by Yaxi Chen
This network shows the impact of papers produced by Yaxi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaxi Chen. The network helps show where Yaxi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaxi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 243 | |
| 2 | CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis Hit paper breakdown → | 2022 | 227 |
| 3 | 2008 | 209 | |
| 4 | 2017 | 204 | |
| 5 | 2021 | 161 | |
| 6 | Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Hit paper breakdown → | 2023 | 153 |
| 7 | 2018 | 116 | |
| 8 | 2018 | 109 | |
| 9 | 2022 | 92 | |
| 10 | 2017 | 60 | |
| 11 | 2013 | 48 | |
| 12 | 2014 | 42 | |
| 13 | 2014 | 39 | |
| 14 | 2022 | 35 | |
| 15 | 2018 | 27 | |
| 16 | 2017 | 22 | |
| 17 | 2016 | 20 | |
| 18 | 2022 | 19 | |
| 19 | 2022 | 19 | |
| 20 | 2020 | 19 |
About Yaxi Chen
Yaxi Chen is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Surgery and Nephrology, having authored 54 papers that have together received 2.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Cancer, Lipids, and Metabolism (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Hepatitis B Virus Studies (3 papers), Diet, Metabolism, and Disease (3 papers), Autophagy in Disease and Therapy (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Lipid metabolism and biosynthesis (3 papers). The work is most often cited by research in Cancer Research (509 citations), Hepatology (159 citations), Nephrology (104 citations), Epidemiology (477 citations) and Biochemistry (106 citations). Yaxi Chen has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xiong Z. Ruan, Zac Varghese, John F. Moorhead, Lei Zhao, Ping Yang, Stephen H. Powis, Han Zeng, Wei Li, Kun Liu and Ping Yang. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications, Cell Death and Disease, Scientific Reports and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.